drugset / Trial / NCT02331693
CAR T Cells in Treating Patients With Malignant Gliomas Overexpressing EGFR
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether autologous T cells bearing chimeric antigen receptor that can specifically recognize EGFR overexpressed in tumor cells is safe and effective for patients with EGFR-overexpressing malignant glioma.
Timeline
- Start
- 2014-12
- Primary completion
- 2015-12
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | anti-EGFR CAR T | Cell therapy | — | Intravenous |